Recent FDA Actions on NSAIDS (June 2005)

Tags:
Recent FDA Actions Nsaids Vioxx Rofecoxib COX-2 Selective Inhibitors Bextra Valdecoxib Patient Safety Skin
LawsuitGuru
  • Affiliate Submitter:
    LawsuitGuru
  • International International
  • Comments: 0
  • Views: 16
  • Added: 10-Jul-08

On April 7, 2005, FDA announced several important changes that pertain to the marketing of non-steroidal anti-inflammatory drugs (NSAIDs). FDA has asked that one product be withdrawn from the market, and is requiring stronger warnings in the labeling for the other products. This is a continuation of the process that began several months ago with Vioxx (rofecoxib), when Merck withdrew that product from the market because of concerns about adverse cardiovascular events. These later actions are ...

  1. Categories: Science & Tech
Comments on

Recent FDA Actions on NSAIDS (June 2005)

0 Comments | Be the first to comment
 
kpins